Closed-Loop Titration of Vasopressor Infusions: Feasibility Study or Proof of Concept Study
CLV
Computer-assisted Vasopressor Infusion for Hemodynamic Optimization in Patients Undergoing High Risk Surgery
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to evaluate the performance of a novel closed-loop (automated) vasopressor administration system that delivers norepinephrine using feedback from standard operating room hemodynamic monitor (EV1000 Monitor-Flotrac or Clearsight system, Edwards Lifesciences, IRVINE, USA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2018
CompletedStudy Start
First participant enrolled
April 26, 2018
CompletedFirst Posted
Study publicly available on registry
May 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 27, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 27, 2018
CompletedSeptember 14, 2018
September 1, 2018
4 months
April 17, 2018
September 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of case Time in hypotension (MAP <65 mmHg) for surgical patients. For potential recrutment of critically ill patients in the ICU, this target can be different (higher, depending on the type of patient and comorbidities)
The primary outcome will be the percentage of case time in predefined MAP target
At postoperative day 1
Secondary Outcomes (2)
percentage of case time with MAP >75 mmHg with norepinephrine still running
At postoperative day 1
Amount of vasopressors received
At postoperative day 1
Study Arms (1)
Closed-loop
EXPERIMENTALStudy patients will receive a baseline crystalloid infusion of 3 cc/kg/hr and all additional fluid management will be performed manually using the assisted fluid management sofware from the EV1000 monitor. A closed-loop system will automatically administer vasopressor based on the predefined target MAP chosen by the anesthesiologist in charge of the patient
Interventions
Vasopressor admnistration in the closed loop group will be performed via a closed loop (automated) system that will use an infusion pump (Q-Core) and a controller (a computer run index and algorithm developed by Sironis) to make frequent, regular and accurate adjustments to the amount of vasopressor the patient receives using feedback from standard operating room monitors.
Eligibility Criteria
You may qualify if:
- Subjects over the age of 18
- Subjects undergoing elective high risk surgery (either vascular-cardiac- or transplant)
- Subjects requiring general anesthesia and mechanical ventilation
- Subjects requiring cardiac output monitoring with an arterial line
You may not qualify if:
- Subjects under 18 years of age
- Subjects not undergoing surgery
- Subjects not requiring general anesthesia or mechanical ventilation
- Subjects not requiring cardiac output monitoring or an arterial line
- Subject with Atrial Fibrillation
- Subjects who are pregnant
- Subjects without the capacity to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erasme
Brussels, Brussels Capital, 1070, Belgium
Related Publications (1)
Joosten A, Alexander B, Duranteau J, Taccone FS, Creteur J, Vincent JL, Cannesson M, Rinehart J. Feasibility of closed-loop titration of norepinephrine infusion in patients undergoing moderate- and high-risk surgery. Br J Anaesth. 2019 Oct;123(4):430-438. doi: 10.1016/j.bja.2019.04.064. Epub 2019 Jun 27.
PMID: 31255290DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Joosten, M.D
Erasme
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 17, 2018
First Posted
May 3, 2018
Study Start
April 26, 2018
Primary Completion
August 27, 2018
Study Completion
August 27, 2018
Last Updated
September 14, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After the completion of the study and the publication of the results
- Access Criteria
- Contact PI
We can provide individual patients data ( all hemodynamic data)